Funding for this research was provided by:
James S. McDonnell Foundation
Defense Threat Reduction Agency (HDTRA1-15-1-0051)
Received: 8 September 2020
Accepted: 15 March 2021
First Online: 19 April 2021
: J.J.C. is scientific co-founder and scientific advisory board chair of EnBiotix, an antibiotic drug discovery company. The remaining authors declare no competing interests.